14-day Premium Trial Subscription Try For FreeTry Free
Winner will receive complimentary sample processing and analysis for high-throughput characterization of microbial communities.
This week in Washington IP, both houses of Congress are quiet during August recess but patent and IP policy issues are front and center at the Hudson Institute, which is hosting events to explore how
CENIC is now able to provide high-capacity services, from 100G to 400G and beyond, on its coastal path between Los Angeles and Sunnyvale. The research
White House unveils partnership to boost quantum science education
HC Wainwright restated their buy rating on shares of Ekso Bionics (NASDAQ:EKSO) in a research report released on Friday, AnalystRatings.com reports. HC Wainwright currently has a $12.00 price target o
IgGenix, Inc, today announced it completed a $10 million Series A financing. The financing was led by Khosla Ventures with participation from Parker V
Fluidigm receives NIH funding for COVID-19 testing technology. Stereotaxis receives positive fillip from first integrated cardiac ablation procedure.
AbCellera today announced that LY-CoV555, a potential treatment and prophylaxis for COVID-19, has progressed to Phase 3 clinical trials.
Giroir’s qualifications have come under increasing scrutiny as the US death toll tops 150,000, and testing continues to lag
Ekso Bionics (EKSO) delivered earnings and revenue surprises of 0.00% and 22.38%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?

Ekso Bionics Reports Second Quarter 2020 Results

08:05pm, Thursday, 30'th Jul 2020
RICHMOND, Calif., July 30, 2020 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”), an industry leader in exoskeleton technology for medical and industrial use, today r
Start Time: 16:30 End Time: 17:00 Ekso Bionics Holdings, Inc. (NASDAQ:EKSO) Q2 2020 Earnings Conference Call July 30, 2020, 16:30 PM ET Company Participants Jack Peurach - President and CEO Jack Glenn
Ekso Bionics (EKSO) Q2 earnings are expected to have been boosted by its recent efforts to grow virtual connectivity with customers and to reduce costs.
In 2021 university teams will compete in an autonomous-car race at Indianapolis Motor Speedway. It’s a reminder how difficult the technology behind autonomous driving is.
RICHMOND, Calif., July 23, 2020 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO), an industry leader in exoskeleton technology for medical and industrial use, today announced that it wil
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE